demand for blood transfusion in cases such as blood loss during surgeries, trauma, and anemia led to growth of synthetic blood substitutes. Increase in incidence of disease seeking medical interventions or surgeries, rise in road accidents, military wars and trauma cases Wayne Gallman Jersey , insufficient number of blood donors, and rise in blood related disorders are the major drivers of the synthetic blood substitutes and blood products market. Advent of stem cell therapy has created new opportunities for players in this market. However, instability and lower shelf life of artificial blood products and stringent regulatory approval process are considered major restraints of the synthetic blood substitutes and blood products market.
Based on product type, the synthetic blood substitutes and blood products market has been segmented into perflurocarbon-based products (PFC), hemoglobin-based oxygen carriers, synthetic platelets, recombinant factors Davis Webb Jersey , and blood expanders. Commonly used PFCs are Perfluorodecalin and Perflubron. Major advantage of PFCs is easy transportation of oxygen throughout the body. However, decrease in blood platelets count is a major side effect of usage of PFC. Hemoglobin-based blood carriers are preferred over PFCs due to longer shelf life. However, hemoglobin-based blood carriers can cause anaphylactic shock when frequently used in patients.
Request Brochure of Report: ;rep_id=26012
In terms of region, the synthetic blood substitutes and blood products market has been segmented into North America, Europe, Asia Pacific, Latin America Dalvin Tomlinson Jersey , and Middle East & Africa. North America is anticipated to hold the largest market share owing to advanced research and development in stem cell therapy.